Indications |
Oral Hyperlipidaemias, Homozygous familial sitosterolaemia Adult: 10 mg once daily. |
Contraindications |
Hypersensitivity; moderate to severe liver disease or unexplained serum transaminase elevation. Children <10 yr, lactation. |
Warnings / Precautions |
Renal or mild hepatic impairment. Monitor LFTs. Immediately discontinue ezetimibe and any HMG-CoA reductase inhibitor or fibrate if myopathy is diagnosed or suspected. Exclude or treat secondary causes of dyslipidaemia prior to initiating therapy. |
Adverse Reactions |
Abdominal discomfort, headache, dizziness, sinusitis, pharyngitis; diarrhoea, chest pain, arthralgia, myalgia, resp infection and fatigue. |
Drug Interactions |
Concomitant admin of ezetimibe with cholestyramine may decrease serum levels of ezetimibe resulting in lower efficacy. Concurrent use of ezetimibe and cyclosporine may lead to increased exposure to both drugs, thus caution should be exercised. See Below for More ezetimibe Drug Interactions |
Mechanism of Actions |
Ezetimibe localises at the brush border of the small intestine where it inhibits the absorption of cholesterol, thus decreasing its delivery to the liver. This results in decrease in cholesterol stores within the liver and an increase in cholesterol clearance from the blood. Absorption: Peak plasma concentrations after 4-12 hr. Distribution: Protein-binding: >90%. Metabolism: Undergoes conjugation in small intestines and liver. Excretion: Faeces (69% unchanged drug); urine (9% metabolite); 22 hr (elimination half-life). |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 25°C. |
ATC Classification |
C10AX09 - ezetimibe ; Belongs to the class of other lipid modifying agents. |
Storage |
Oral: Store at 25°C. |
Available As |
|
Ezetimibe
Post Review about Ezetimibe Click here to cancel reply.
Ezetimibe Containing Brands
Ezetimibe is used in following diseases
Drug - Drug Interactions of Ezetimibe
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.